Published in J Cardiovasc Nurs on May 20, 2016
Discordant Perceptions of Prognosis and Treatment Options Between Physicians and Patients With Advanced Heart Failure. JACC Heart Fail (2017) 0.77
Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond. Curr Heart Fail Rep (2017) 0.75
The Decisions, Interventions, and Goals in ImplaNtable Cardioverter-DefIbrillator TherapY (DIGNITY) Pilot Study. J Am Heart Assoc (2017) 0.75
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med (2009) 14.13
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol (2014) 9.96
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA (2004) 9.74
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Spironolactone for heart failure with preserved ejection fraction. N Engl J Med (2014) 7.48
Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med (2010) 5.48
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial. JAMA (2013) 5.31
Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail (2013) 4.98
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol (2007) 4.74
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome. N Engl J Med (2015) 4.56
Health literacy and outcomes among patients with heart failure. JAMA (2011) 4.13
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Slower walking speed forecasts increased postoperative morbidity and 1-year mortality across surgical specialties. Ann Surg (2013) 3.15
Contemporary evidence about hospital strategies for reducing 30-day readmissions: a national study. J Am Coll Cardiol (2012) 3.12
Oral high-dose multivitamins and minerals after myocardial infarction: a randomized trial. Ann Intern Med (2013) 3.08
Trends in incidence, severity, and outcome of hospitalized myocardial infarction. Circulation (2010) 3.07
Provision of spiritual care to patients with advanced cancer: associations with medical care and quality of life near death. J Clin Oncol (2009) 2.85
Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF). Circulation (2010) 2.77
CPAP versus oxygen in obstructive sleep apnea. N Engl J Med (2014) 2.75
Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J (2003) 2.61
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation (2009) 2.57
Bilateral internal thoracic artery harvest and deep sternal wound infection in diabetic patients. Ann Thorac Surg (2013) 2.54
Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study. J Natl Cancer Inst (2012) 2.21
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J Am Coll Cardiol (2003) 2.14
Mechanisms of bleeding and approach to patients with axial-flow left ventricular assist devices. Circ Heart Fail (2011) 2.11
Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis (2011) 2.05
Heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Circ Heart Fail (2008) 1.97
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes (2011) 1.88
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation (2011) 1.87
The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT). Circ Cardiovasc Qual Outcomes (2013) 1.84
Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc (2007) 1.84
Brain-selective overexpression of angiotensin (AT1) receptors causes enhanced cardiovascular sensitivity in transgenic mice. Circ Res (2002) 1.81
Associations between outpatient heart failure process-of-care measures and mortality. Circulation (2011) 1.77
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm (2010) 1.74
Hospital strategies associated with 30-day readmission rates for patients with heart failure. Circ Cardiovasc Qual Outcomes (2013) 1.72
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet (2008) 1.69
Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol (2011) 1.69
ACC 2009 survey results and recommendations: Addressing the cardiology workforce crisis A report of the ACC board of trustees workforce task force. J Am Coll Cardiol (2009) 1.67
Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail (2011) 1.64
Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail (2012) 1.62
Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol (2007) 1.58
Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction. Eur Heart J (2012) 1.58
Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF. Am Heart J (2012) 1.57
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy. Physiol Genomics (2006) 1.57
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial. Eur Heart J (2004) 1.55
Patient preference in the decision to place implantable cardioverter-defibrillators. Arch Intern Med (2012) 1.53
Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm (2009) 1.53
Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak (2013) 1.51
Severity of intraoperative tricuspid regurgitation predicts poor late survival following cardiac transplantation. Ann Thorac Surg (2004) 1.49
Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. J Am Coll Cardiol (2008) 1.48
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur Heart J (2013) 1.47
Is off-pump coronary artery bypass grafting superior to conventional bypass in octogenarians? J Thorac Cardiovasc Surg (2010) 1.47
Simple frailty score predicts postoperative complications across surgical specialties. Am J Surg (2013) 1.46
Cytokine expression profile in human lungs undergoing normothermic ex-vivo lung perfusion. Ann Thorac Surg (2011) 1.44
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). Am J Cardiol (2010) 1.43
Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail (2011) 1.39
When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure. Circulation (2012) 1.39
Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis. J Am Coll Cardiol (2012) 1.38
Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol (2009) 1.35
Economic burden of heart failure in the elderly. Pharmacoeconomics (2008) 1.34
Impact of erythropoiesis-stimulating agents on energy and physical function in nondialysis CKD patients with anemia: a systematic review. Am J Kidney Dis (2009) 1.31
Frailty and healthcare utilization among patients with heart failure in the community. JACC Heart Fail (2013) 1.29
Frailty and the selection of patients for destination therapy left ventricular assist device. Circ Heart Fail (2012) 1.28
Characteristics of patients who die with heart failure and a low ejection fraction in the new millennium. J Card Fail (2006) 1.25
Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol (2008) 1.24
Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail (2009) 1.24
Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70. Am J Physiol Heart Circ Physiol (2009) 1.18
Palliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 1.17
Long-term medication adherence after myocardial infarction: experience of a community. Am J Med (2009) 1.14
Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. Am Heart J (2007) 1.14
Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil (2011) 1.12
Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2. J Thorac Cardiovasc Surg (2009) 1.12
Β-arrestin: a signaling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol (2010) 1.11
ACCF 2012 health policy statement on patient-centered care in cardiovascular medicine: a report of the American College of Cardiology Foundation Clinical Quality Committee. J Am Coll Cardiol (2012) 1.11
Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J (2009) 1.11
Cardiohepatic interactions in heart failure: an overview and clinical implications. J Am Coll Cardiol (2013) 1.10
Patient-identified factors related to heart failure readmissions. Circ Cardiovasc Qual Outcomes (2013) 1.10
Attenuation of spinal cord ischemia and reperfusion injury by erythropoietin. J Thorac Cardiovasc Surg (2011) 1.08
Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation (2012) 1.08
Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation (2013) 1.07
Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis. Ann Thorac Surg (2008) 1.06
The association between high-dose diuretics and clinical stability in ambulatory chronic heart failure patients. J Card Fail (2008) 1.06
Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT). Eur J Heart Fail (2010) 1.06
Postdischarge environment following heart failure hospitalization: expanding the view of hospital readmission. J Am Heart Assoc (2013) 1.05
Event-free survival following CRT with surgically implanted LV leads versus standard transvenous approach. Pacing Clin Electrophysiol (2011) 1.04
Biglycan induces the expression of osteogenic factors in human aortic valve interstitial cells via Toll-like receptor-2. Arterioscler Thromb Vasc Biol (2012) 1.04
Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial. Eur J Heart Fail (2010) 1.04
Estimated glomerular filtration rate, inflammation, and cardiovascular events after an acute coronary syndrome. Am Heart J (2008) 1.04